Pentraxin 3 concentration is associated with poor outcomes in patients with coronary artery disease: a systematic review and dose-response meta-analysis.
William Kamarullahnull NurcahyaniRachmatu Bill MultazamClaudia Mary JosephinePublished in: Acta cardiologica (2021)
A significant positive dose-dependent association between circulating PTX3 concentration and the risk of poor outcomes in patients with CAD was found in this dose-response meta-analysis.